| Post | Subject | | |
|
#31
|
New preclinical data https://www.globenewswire.com/news-release/2022/05/02/24333
|
jondoeuk
| 05/02/22 12:06:00 PM |
|
#30
|
Also, https://jitc.bmj.com/content/8/Suppl_3/A103.2
|
jondoeuk
| 02/13/22 08:08:33 PM |
|
#29
|
https://www.fiercebiotech.com/research/engineered-tcr-t-cells-by-fred-hutch-san-
|
jondoeuk
| 02/09/22 06:18:02 PM |
|
#28
|
ASH abstracts
|
jondoeuk
| 11/04/21 02:17:49 PM |
|
#27
|
PR https://www.globenewswire.com/news-release/2021/10/20/2317270/0/en/Intellia-T
|
jondoeuk
| 10/20/21 03:16:26 PM |
|
#26
|
The company will present new data at the
|
jondoeuk
| 10/12/21 12:42:29 PM |
|
#25
|
The company has announced that it has submitted
|
jondoeuk
| 08/05/21 01:03:06 PM |
|
#24
|
And BEAM
|
Glider549
| 06/30/21 12:05:40 PM |
|
#23
|
Sudden burst in genomic stocks. NTLA, EDIT, CRSP
|
Gpheart2016
| 06/30/21 11:22:23 AM |
|
#22
|
Big gap and lot of money to be
|
make it happen
| 06/29/21 07:02:03 AM |
|
#21
|
You do understand that this is a biotech
|
go_glortho
| 06/28/21 05:41:00 PM |
|
#20
|
Large negatives across the board. Revenue Per Share $0.86
|
make it happen
| 06/28/21 11:57:06 AM |
|
#19
|
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia
|
jondoeuk
| 06/24/21 03:30:19 PM |
|
#18
|
Adding CD8 coreceptors may enhance CD4+ T-cell responses
|
jondoeuk
| 04/30/21 09:59:09 PM |
|
#17
|
Knock-ins, knockdowns and/or overexpression are other ways to
|
jondoeuk
| 04/30/21 09:50:55 PM |
|
#16
|
In the setting of established and (rapidly) proliferating
|
jondoeuk
| 04/30/21 09:43:58 PM |
|
#15
|
This was presented at SITC last year https://jitc.bmj.com/content/8/Suppl_3/A103
|
jondoeuk
| 04/30/21 04:21:06 PM |
|
#14
|
This trial showed that donor-derived, CD8+ T-cells engineered
|
jondoeuk
| 04/30/21 04:19:29 PM |
|
#13
|
https://www.businesswire.com/news/home/20210107005234/en/ArsenalBio-Announces-Mu
|
jondoeuk
| 01/09/21 05:49:48 PM |
|
#12
|
Cathie Wood likes some cutting edge Gene editing
|
Fress
| 01/07/21 10:28:57 AM |
|
#11
|
NTLA 5001, a T Cell Product Candidate with
|
jondoeuk
| 12/05/20 01:22:47 PM |
|
#10
|
Arsenal Bio [1] is also using it for
|
jondoeuk
| 11/25/20 02:59:16 PM |
|
#9
|
Currently, the company is using CRISPR/Cas9 screening to
|
jondoeuk
| 11/25/20 02:58:37 PM |
|
#8
|
Preclinical data (at ASH) https://ashpublications.org/blood/article/136/Suppleme
|
jondoeuk
| 11/04/20 06:06:01 PM |
|
#7
|
Bought more at $18.30 before selling all @
|
chmcnfunds
| 01/08/18 01:50:15 PM |
|
#6
|
CRISPR hits a snag: Our immune systems may
|
chmcnfunds
| 01/08/18 10:57:51 AM |
|
#5
|
In at $18.90. Got to believe the drop
|
chmcnfunds
| 01/08/18 10:56:50 AM |
|
#4
|
I don't have enough understanding on how the
|
rule_rationale
| 10/09/17 01:19:13 PM |
|
#3
|
Am I the only one that thinks this
|
jimski55
| 10/06/17 03:38:42 PM |
|
#2
|
Which of the big three is closest to
|
redspinelpinktopaz
| 03/07/17 02:18:43 PM |
|
#1
|
Took a starter here, CRISPR could do amazing things!
|
rule_rationale
| 05/10/16 11:00:34 AM |
| Post | Subject | | |